Full access
Professional News
Published Online: 31 October 2017

The “Night Owl” Gene

Publication: Psychiatrics News
Volume 52, Number 21
https://doi.org/10.1176/appi.pn.2017.11a50
People with delayed sleep phase disorder (DSPD) typically cannot fall asleep until 3 a.m. or 4 a.m., or even later. They find it hard to start work or school at conventional times. Because they often cut sleep short, they commonly experience extreme fatigue.
In June Alina Patke, Ph.D., a research associate working with Michael W. Young, Ph.D., and others, reported in Cell that her group had identified a mutation of the human circadian clock gene CRY1 in familial DSPD. CRY1 was quickly dubbed the “night owl” gene.
The mutation makes one of CRY1’s proteins overactive. People with the mutation have a longer than average circadian cycle and markedly delayed sleep.
The researchers found the CRY1 mutation in a 46-year-old woman who had been diagnosed with DSPD on the basis of her sleep logs and laboratory studies of her sleep, hormones, body temperature, and other circadian rhythms. They found the same mutation in other late-to-bed family members, inherited in an autosomal dominant pattern.
DSPD is the most commonly diagnosed circadian rhythm sleep disorder. About 0.1 percent of the population worldwide carries the CRY1 mutation, Young said at a press conference at Rockefeller University on October 2, responding to a reporter’s query about potential practical payoffs from his research.
“We now have ways of thinking about how we might want to attack a medical problem where a gene is hyperactive,” Young said.
The DSPD finding provides the identity of a mutation prevalent in the human population, he added. “It gives us a target to work on. Previously, we didn’t know this was an inherited disorder. I think we’re going to run into this over and over again, not only in this system but in many others.” ■
“Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder” can be accessed here.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatrics News
Volume 52 • Number 21 • October 21, 2017 – November 3, 2017
Pages: 1

History

Published online: 31 October 2017
Published in print: October 21, 2017 – November 3, 2017

Keywords

  1. Night owl gene
  2. Alina Patke
  3. Michael W. Young

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.